Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?

Breast Cancer Research and Treatment

Volumn 72, Issue 3, 2002, Pages 245-253

  Garuti, Giancarlo ^a   Grossi, Francesco ^a   Cellani, Fulvia ^a   Centinaio, Giovanna ^a   Colonnelli, Monica ^a   Luerti, Massimo ^a  

^a Lodi Hospital   (Italy)

Author keywords

Breast cancer; Endometrial cancer; Hysteroscopy; Tamoxifen; Transvaginal Ultrasonography

Indexed keywords

TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ARTICLE; BREAST CANCER; DIAGNOSTIC ACCURACY; ENDOMETRIUM ATROPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; MAJOR CLINICAL STUDY; MENOPAUSE; POLYP; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARD; TRANSVAGINAL ECHOGRAPHY; UTERUS BLEEDING; BREAST TUMOR; COMPARATIVE STUDY; ECHOGRAPHY; ENDOMETRIUM; ENDOMETRIUM TUMOR; MIDDLE AGED; PATHOLOGY;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYSTEROSCOPY; MENOPAUSE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TAMOXIFEN;

EID: 0036010916     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014957524845     Document Type: Article

References (38)

1. Tamoxifen for early breast cancer: An overview of the randomised trials
2. Clinical aspects and development of antioestrogen therapy: A review of the endocrine effects of tamoxifen in animals and men
3. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P- 1 Study
4. Hormonal therapy for advanced breast cancer
5. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
6. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
7. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening
8. Guidelines for monitoring patients taking tamoxifen treatment
9. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: A prospective long-term study using transvaginal ultrasound
10. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen
11. Saline infusion sonography: A diagnostic and therapeutic intervention for patients on tamoxifen
12. Value of sonohysterography in asymptomatic postmenopausal tamoxifen treated patients
13. Transvaginal ultrasonography of the endometrium in women with post-menopausal bleeding. A nordic multicenter study
14. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases
15. A 2500 out-patients diagnostic hysteroscopies
16. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen
17. Tamoxifen and the endometrium: Finding of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients
18. Hysteroscopic evaluation of the endometrium in postmenopausal women taking tamoxifen
19. Endometrial changes in patients on tamoxifen
20. Hysteroscopic differential diagnosis of the endometrium
21. Biopsy Pathology of the Endometrium
22. Risk of endometrial cancer after tamoxifen treatment of breast cancer
23. Iatrogenic risk of endometrial carcinoma after treatment for breast cancer in a large french case-control study
24. Abnormalities detected on transvaginal ultrasonography in tamoxifen treated postmenopausal breast cancer patients may represent endometrial cystic atrophy
25. Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen
26. Transvaginal endometrial sonography in postmenopausal women taking tamoxifen
27. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen
28. Endometrial thickness in tamoxifen-treated patients: An independent predictor of endometrial disease
29. Feasibility and pain control in out patient hysteroscopy in postmenopausal women: A randomized trial
30. Complications of hysteroscopy: A prospective, multicenter study
31. Discrepancy between ultra-sonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen
32. Hysteroscopy with selective endometrial sampling compared with dilatation and curettage for abnormal uterine bleeding: The value of a negative hysteroscopic view
33. Hysteroscopy and transvaginal ultrasonography in postmenopausal women with uterine bleeding
34. Longitudinal hysteroscopic follow-up during tamoxifen treatment
35. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen
36. Endometrial cancer in polyps associated with tamoxifen use
37. Endometrial cancers in postmenopausal breast cancer patients with tamoxifen treatment
38. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen